Close
  Indian J Med Microbiol
 

Figure 5: Effects of Lysiphyllum strychnifolium on the plasma uric acid concentration on potassium oxonate-induced hyperuricemic mice (a) and rate of uric acid production in homogenated mice livers (b). Group 1 represents normal control group; Group 2 means untreated-potassium oxonate induced hyperuricemic mice; Group 3 represents potassium oxonate-induced hyperuricemic mice treated with allopurinol (5 mg/kg); groups 4 and 5 represent potassium oxonate-induced hyperuricemic mice treated with 100 and 200 mg/kg of Lysiphyllum strychnifolium, respectively. Data are expressed as mean ± standard error of the mean (n = 6–8). ##represents P < 0.01, compared to normal control mice, respectively, compared to normal control mice. * and ** represent P < 0.05 and P < 0.01 respectively, compared to untreated potassium oxonate-induced hyperuricemic mice

Figure 5: Effects of <i>Lysiphyllum strychnifolium</i> on the plasma uric acid concentration on potassium oxonate-induced hyperuricemic mice (a) and rate of uric acid production in homogenated mice livers (b). Group 1 represents normal control group; Group 2 means untreated-potassium oxonate induced hyperuricemic mice; Group 3 represents potassium oxonate-induced hyperuricemic mice treated with allopurinol (5 mg/kg); groups 4 and 5 represent potassium oxonate-induced hyperuricemic mice treated with 100 and 200 mg/kg of <i>Lysiphyllum strychnifolium</i>, respectively. Data are expressed as mean ± standard error of the mean (<i>n</i> = 6–8). <sup>##</sup>represents <i>P</i> < 0.01, compared to normal control mice, respectively, compared to normal control mice. * and ** represent <i>P</i> < 0.05 and <i>P</i> < 0.01 respectively, compared to untreated potassium oxonate-induced hyperuricemic mice